Victória Riquena Grosche
Victória Riquena Grosche, PhD is an expert in Virology at Federal University of Uberlândia (Brazil). Victória Riquena Grosche has authored 18 publications, the most recent in 2026. SLR score: 64 (community average: 125). How the SLR is computed.
LeadR Profile
Virology
Subspecialties: Infectiology - Pharmacy - Dentistry
Main Topics
Publications and Clinical Studies
Profile data updated on
Organizations
Career arc: 2020 - 2026Federal University of Uberlândia
2020 - 2026
São Paulo State University
2020 - 2026
Fundação para o Desenvolvimento da UNESP
2024 - 2026
University of Leeds
2025 - 2026
Number : 18
Citations
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Antiviral potential of galactose-binding lectin from Vatairea macrocarpa seeds against SARS-CoV-2. PMID 42155355 — cells, sars-cov-2, galectins, polysaccharides, drug therapy, seeds, viruses, galactose, research, severe acute respiratory syndrome-related coronavirus, antiviral agents, infections, virus diseases, lectins | Biomed Pharmacother | 2026 | 0 |
| Copper(II) benzyloxychalcone analogues as new potential metallodrugs against SARS-CoV-2 replication. PMID 42084032 — sars-cov-2, chalcones, virology, viruses, severe acute respiratory syndrome-related coronavirus, antiviral agents | J Gen Virol | 2026 | 0 |
| Lisboaeflavanonol A: a novel Amazonian molecule as a potent antiviral compound with activity against SARS-CoV-2. PMID 41967233 — cells, sars-cov-2, viruses, plants, medicinal, herbal medicine, severe acute respiratory syndrome-related coronavirus, antiviral agents | Phytomedicine | 2026 | 0 |
| Synthetic Mimotopes of Salivary Peptides against SARS-CoV-2 In Vitro. PMID 40817788 — cells, sars-cov-2, dentistry, virus replication, covid-19, research, therapeutics, severe acute respiratory syndrome-related coronavirus, cell death, antiviral agents | J Dent Res | 2025 | 0 |
| Kaurenoic acid is a potent inhibitor of SARS-CoV-2 RNA synthesis, virion assembly, and release in vitro. PMID 40415937 — coronavirus, sars-cov-2, virion, covid-19, viruses, peptide hydrolases, severe acute respiratory syndrome-related coronavirus, antiviral agents, rna | Front Microbiol | 2025 | 0 |
LeadR Networks
Main global connection map